Surgery and anesthesia
Conditions
Interventions
Test group:On the basis of the control group, 0.75mg of taglidine was administered intravenously during anesthesia induction.
Sponsors
The First Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. Age: 18-64 years old; 2. Undergo painless hysteroscopic diagnosis and treatment; 3. BMI21-24kg/m^2, preoperative ASA grade ? - ?; 4. Be informed of the research and participate voluntarily.
Exclusion criteria
Exclusion criteria: 1. Major organ diseases; 2. Immune function impairment; 3. Abnormal coagulation mechanism; 4. Mental illness; 5. Allergy to anesthetics; 6. Patients with severe respiratory depression or oxygen saturation below 90%; 7. It is contraindicated in patients with known or suspected gastrointestinal obstruction, including paralytic intestinal obstruction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analog scale, VAS;Adverse reactions: Incidence rates of hypotension, respiratory depression, intraoperative body movement, nausea, vomiting, and constipation; | — |
Secondary
| Measure | Time frame |
|---|---|
| mean arterial pressure, MAP;heart rate, HR;SpO2;respiratory rate, RR;bispectral index, BIS;propofol consumption;Time from stopping medication to opening eyes; | — |
Countries
China
Contacts
Public ContactQin Yi
Department of Anesthesiology, the First Affiliated Hospital of Guangxi Medical University
Outcome results
None listed